During the past decade, Charite - Campus Virchow-Klinikum conducted 118 clinical trials. In the 10-year time frame, 118 clinical trials started and 65 clinical trials were completed, i.e. on average, 55.1% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 36 clinical trials were completed. i.e. 94.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charite - Campus Virchow-Klinikum" #1 sponsor was "Eli Lilly and Company" with 14 trials, followed by "Boston Scientific Corporation" with 9 trials sponsored, "Pfizer" with 9 trials sponsored, "Amgen" with 8 trials sponsored and "Gilead Sciences" with 8 trials sponsored. Other sponsors include 185 different institutions and companies that sponsored additional 126 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charite - Campus Virchow-Klinikum" #1 collaborator was "Novartis" with 5 trials as a collaborator, "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 111 different institutions and companies that were collaborators in the rest 112 trials.

According to Clinical.Site data, the most researched conditions in "Charite - Campus Virchow-Klinikum" are "Ovarian Cancer" (15 trials), "Heart Failure" (10 trials), "Ulcerative Colitis" (9 trials), "Crohn's Disease" (8 trials) and "Coronary Artery Disease" (7 trials). Many other conditions were trialed in "Charite - Campus Virchow-Klinikum" in a lesser frequency.

Most popular intervention types in "Charite - Campus Virchow-Klinikum" are "Drug" (165 trials), "Device" (39 trials), "Biological" (21 trials), "Procedure" (20 trials) and "Other" (15 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (41 trials), "radiation therapy" (9 trials), "cyclophosphamide" (7 trials), "carboplatin" (6 trials) and "filgrastim" (6 trials). Other intervention names were less common.

The vast majority of trials in "Charite - Campus Virchow-Klinikum" are 213 trials for "All" genders, 24 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Charite - Campus Virchow-Klinikum". undefined are not yet recruiting, 28 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 139 completed trials in Charite - Campus Virchow-Klinikum, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Charite - Campus Virchow-Klinikum, 23 "Phase 1" clinical trials were conducted, 64 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 23 trials, and there were also 27 trials that are defined as “Not Applicable".